This July 10, 2006 file photo.Inc.Expected to release second-quarter earnings after the bell, Wednesday, April 11, 2007.Sakuma Dec.2007 Font Size WASHINGTON (AP) - A panel of government advisers said Wednesday Genentech drug Avastin should not be approved for expanded use in breast-cancer patients.Full Coverage After weighing evidence on whether the drug meaningfully improves life for patients with advanced breast cancer, panelists voted 5 to 4 against rmending approval.Francisco-based Genentech asked the Food and Drug Administration to approve the drug for use alongside chemotherapy for breast cancer patients.Prior to the meeting, FDA scientists said that while Avastin slowed the progression of cancer, it did not improve patients' lifespan overall.Shares of Genentech fell 6.9 percent, to $66.Trading in the stock was halted at 2:29 p.EST.Of 2:45 p.Trading had not yet resumed.Read more Topiramate appears to promote weight loss in patients with antipsychotic-induced weight gain
Get more Sertraline hydrochloride(sertraline hydrochloride) tablet, film coated sertraline hydrochloride(sertraline hydrochloride) solution, concentrate [greenstone, ltd.]
